BioCentury
ARTICLE | Company News

BTG in ketone deal with Shimizu

February 2, 2001 8:00 AM UTC

Shimizu Pharmaceutical (Nagoya City, Japan) granted BTG (LSE:BGC) exclusive rights to Shimizu's technology for developing parenteral solutions containing ketone bodies (beta-hydroxybutyrate and/or ace...